CINSF:OTC-China Taiping Insurance Holdings Company Limited (USD)

COMMON STOCK | |

Last Closing

USD 0.8765

Change

0.00 (0.00)%

Market Cap

USD 10.35B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-26 )

Largest Industry Peers for

Symbol Name Price(Change) Market Cap
NCRRP NCR Corp Pref A

N/A

USD 137.98B
STMZF Scottish Mortgage Investment T..

-0.06 (-0.55%)

USD 16.47B
SHZHY Shenzhou International Group H..

-0.02 (-0.14%)

USD 14.31B
PSZKF Powszechna Kasa Oszczednosci B..

N/A

USD 13.13B
CLEGF Coles Group Ltd

N/A

USD 12.70B
ELPQF El Puerto de Liverpool S.A.B. ..

N/A

USD 12.47B
PSHZF Pershing Square Holdings Ltd

+0.61 (+1.17%)

USD 10.25B
IDKOF Idemitsu Kosan Co.Ltd

+0.01 (+0.08%)

USD 9.59B
ELMUY Elisa Oyj

N/A

USD 7.84B
TELDY Telefónica Deutschland Holdin..

N/A

USD 7.71B

ETFs Containing CINSF

N/A

Market Performance

  Market Performance vs. Industry/Classification () Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain 8.21% N/A N/A 70% C-
Dividend Return 36.20% N/A N/A 95% A
Total Return 44.41% N/A N/A 86% B+
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -14.51% N/A N/A 18% F
Dividend Return -8.14% N/A N/A 22% F
Total Return 6.37% N/A N/A 73% C
Risk Return Profile  
Volatility (Standard Deviation) 26.76% N/A N/A 77% C+
Risk Adjusted Return -30.43% N/A N/A 21% F
Market Capitalization 10.35B N/A N/A 90% A-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike